Opinion

Video

Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s Disease

Author(s):

Stuart H. Isaacson, MD, FAAN,Rajesh Pahwa, MD

Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.

Timecodes:

1:28 Defining ON time in PD

4:50 Dyskinesia experience

8:00 Tremor and dyskinesia

13:30 Dyskinesia and QoL

16:00 Dyskinesia and OFF

19:30 Tailoring treatment

22:00 Amantadine DR/ER

29:00 Amantadine candidates

Related Videos
Related Content
Fabio A. Barbieri, PhD (Credit: MOVI-LAB UNESP)
November 22nd 2024

Coupling Eye Movements and Postural Sway Significantly Enhances Stability in Parkinson Disease

Isabella Ciccone, MPH
Multisymptomatic Care in Parkinson's Disease
September 4th 2024

Multisymptomatic Care in Parkinson's Disease

Stuart H. Isaacson, MD, FAAN Rajesh Pahwa, MD Jennifer G. Goldman, MD, MS
Phase 3 ARISE Trial of Parkinson Therapy Solengepras Begins Dosing
November 19th 2024

Phase 3 ARISE Trial of Parkinson Therapy Solengepras Begins Dosing

Marco Meglio
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
April 9th 2024

Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease

Anne Marie Morse, DO, FAASM NeurologyLive® Staff
Parkinson Immunotherapy ACI-7104.056 Demonstrates Positive Antibody Responses in Phase 2 Trial Update
November 15th 2024

Parkinson Immunotherapy ACI-7104.056 Demonstrates Positive Antibody Responses in Phase 2 Trial Update

Marco Meglio
Ali Rezai, MD (Credit: West Virginia University)
November 14th 2024

GAD-Related Parkinson Gene Therapy AAV-GAD Demonstrates Efficacy in Topline Findings

Isabella Ciccone, MPH
© 2024 MJH Life Sciences

All rights reserved.